TRI-SPECIFIC KILLER ENGAGERS TARGET NATURAL KILLER CELLS TOWARDS MESOTHELIOMAJOURNAL FOR IMMUNOTHERAPY OF CANCERIF10.62022-11-070OA
TARGETING PAN-TUMOR ASSOCIATED ANTIGEN B7H3 VIA COMBINATION OF TRI-SPECIFIC KILLER ENGAGER AND OFF-THE-SHELF NK CELL THERAPY ENHANCES SPECIFICITY AND FUNCTION AGAINST A BROAD RANGE OF SOLID TUMORSJOURNAL FOR IMMUNOTHERAPY OF CANCERIF10.62020-11-092PREAI